No abstract available
Keywords:
FDA approval; amyotrophic lateral sclerosis; biomarker; clinical trial; expanded access program.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Amyotrophic Lateral Sclerosis*
-
Humans
-
United States
-
United States Food and Drug Administration